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Obesity and decreased final height are described in chil-
dren with CAH 21OHD. Of 119 children (50 M, 69F;79
Salt Wasters(SW), 40 Simple Virilizers (SV)) diagnosed
over 24 years, various growth parameters were studied
in 43 children with regular follow up for 5 years or
more.
Clinical data, anthropometry, genotype, hormonal and
biochemical profile were evaluated at presentation. On
follow up, growth and clinical characteristics, metabolic
control (8am 17OH-Progesterone), bone age and repla-
cement doses of gluco-corticoid (GC) and mineralo-cor-
ticoid (MC) were studied. Growth parameters were
expressed as SDS. Obesity, defined as BMI SDS >/= 2
and short stature, defined as Ht SDS </= -2 were corre-
lated with all the variables, using Unpaired T Test, Pear-
son Correlation and One way ANOVA Test.
43 children (16M, 27F; 32SW, 11SV; 36 mutations
proven) had a mean duration of follow up of 11 +/-
4.14 years. At last follow up, Ht SDS was </= -2 in
27.9% cases (N=12/43: 4M, 8F; 9SW, 3SV). Age at onset
of puberty (p=0.035), higher GC dose at presentation
(>40mg/m2) (p=0.034) and at 3 years of age (p=0.047)
and use of Hydrocortisone and/or Prednisolone
(p=0.002) had a negative correlation with Ht SDS. 6
(13.95%) children (1M, 5F; 6SW) had achieved Adult
Height (AH) SDS of -2.36 +/- 1.25, and AH SDS – TH
SDS (Target Height) was -0.11 +/- 1.23. BMI SDS >/=2
found in 32.6% cases (N=14/43: 2M, 12F; 8SW, 6SV)
correlated positively with 17 OHP values (p=0.013).
Girls were heavier than boys (p=0.006). Adiposity
rebound occurred at 4 years for both the genders. At
the time of study analysis, Ht SDS showed a distinct
shift to the left and BMI SDS, a distinct shift to the
right of mean of the reference population as cited [1].
In the present series, there was a higher incidence of
obesity (32.6%) but short stature was noted in 27.9%
only. Aggressive lifestyle management, dietary control,
optimizing dose of therapy (GC) and regular monitoring
should be an integral part of long term management of
patients with CAH 21OHD.
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